Enlivex Treasury Portfolio Update: Rain Protocol Jumps Into Top Three Global Prediction Markets In League Table Following $100M In Additional Liquidity
Rhea-AI Summary
Enlivex (Nasdaq: ENLV) reported updated exposure to the Rain prediction markets protocol treasury.
As of May 26, 2026, Enlivex held about 79.6 billion RAIN tokens valued near $919 million and an option on up to 271.4 billion additional tokens, while Rain received a $100 million liquidity commitment that positions it among the top three global prediction markets by TVL.
AI-generated analysis. Not financial advice.
Positive
- Holds about 79,568,550,005 RAIN tokens valued near $919 million as of May 26, 2026
- Option to purchase up to 271,372,418,179 RAIN tokens at $0.0033 per token
- RAIN option intrinsic value of approximately $2.23 billion as of May 26, 2026
- $100 million Rain liquidity pool supports top-three global prediction market TVL position
Negative
- None.
News Market Reaction – ENLV
On the day this news was published, ENLV gained 14.33%, reflecting a significant positive market reaction. Argus tracked a peak move of +16.7% during that session. Our momentum scanner triggered 10 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $25M to the company's valuation, bringing the market cap to $202.48M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
ENLV is down 4.67% while biotech peers show mixed moves: AKTX up 31.05%, QTTB up 20.58%, ICU down 5.54%, TENX down 3%. Momentum scanner peers (QTTB, AKTX, CVKD) are split between gains and losses, supporting a stock-specific reaction rather than a coordinated sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| May 18 | Phase 2b dosing | Positive | -3.2% | First U.S. patient dosed in global Phase 2b Allocetra trial. |
| May 15 | Nasdaq bid notice | Negative | -3.2% | Nasdaq notification on failure to meet $1.00 minimum bid price. |
| Apr 30 | RAIN HTX listing | Positive | +2.3% | RAIN token listed on HTX, expanding access and liquidity. |
| Apr 28 | Treasury RAIN update | Positive | -6.4% | RAIN holdings and option position expanded, highlighting discounted strike. |
| Apr 23 | Phase IIa data | Positive | +2.0% | Phase IIa data show significant pain reduction and functional improvement. |
Recent ENLV news — both clinical and Rain/treasury related — has produced mixed reactions, with some positive clinical and treasury milestones sold off, while other similar positives were bid up, indicating inconsistent news-price alignment.
Over the last few months, Enlivex combined clinical progress in Allocetra™ with expansion of its Rain-based treasury. On Apr 23, 2026, it highlighted positive Phase IIa data, followed by an Apr 28 treasury update detailing rising RAIN holdings and a discounted option. The Apr 30 HTX listing aimed to deepen RAIN liquidity. In May, focus shifted to Phase 2b U.S. dosing and a Nasdaq minimum bid notice. Today’s Rain liquidity and valuation update extends this treasury-focused narrative.
Regulatory & Risk Context
An effective Form F-3 shelf dated Apr 21, 2026 registers up to 23,333,333 ordinary shares for resale tied to a $21.0 million senior secured convertible note. Proceeds from these resales go to the selling shareholder, not Enlivex, and a 424B3 from May 1, 2026 reflects active usage of this resale registration.
Market Pulse Summary
The stock surged +14.3% in the session following this news. A strong positive reaction aligns with the article’s emphasis on expanded Rain liquidity and the scale of Enlivex’s treasury exposure, including RAIN holdings valued at $919 million and an option with $2.23 billion intrinsic value as of May 26, 2026. Past news has sometimes seen both aligned and divergent moves, so investors would have weighed volatility in digital assets and the resale shelf for 23,333,333 shares when assessing durability.
Key Terms
prediction market financial
total value locked (tvl) financial
usdt financial
liquidity pool financial
decentralized prediction market protocol technical
token financial
AI-generated analysis. Not financial advice.
- Rain, with an additional
$100 Million Liquidity Commitment, Currently Anchors Top Three Positioning Among Global Prediction Market Leaders, Following Polymarket, with Approximately$450 million , and Kalshi1. - Rain’s Upgraded Positioning as a Top-3 Prediction Market and the Scale of its Capital Deployment Reinforce the Potential of the Enlivex Treasury Strategy
- As of May 26, 2026, Enlivex's RAIN token holdings were 79,568,550,005 tokens, with a total value of approximately
$919 million . - In addition, Enlivex holds an option to acquire up to 271,372,418,179 RAIN tokens from the Rain Foundation, at a purchase price of
$0.0033 per RAIN token. The option’s expiration date is Dec. 31, 2027. The option’s intrinsic value was$2.23 billion as of May 26, 2026.
Nes-Ziona, Israel, May 27, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, "Enlivex" or the "Company"), a quality longevity company powered by a prediction markets treasury, today commented on the Rain Foundation's announcement of a
According to the Rain Foundation, the additional
As of May 2026, Polymarket leads the prediction market category with approximately
Shai Novik, Executive Chairman of Enlivex, said, "We believe that Rain's positioning among the three largest prediction market platforms globally is a major step in Rain’s quest to become a leading decentralized prediction market protocol, and a meaningful validation of our treasury strategy. We further believe that the scale of capital deployment reflects strong conviction in the continued growth of Rain, and reinforces our confidence in the dual strategy we have built for Enlivex."
Enlivex currently holds approximately 79,568,550,005 RAIN tokens and expects continued maturation of the prediction markets ecosystem to reinforce the strategic positioning of its treasury holdings.
About Enlivex (Nasdaq: ENLV)
Enlivex is a quality longevity company powered by a prediction markets treasury. The Company is advancing Allocetra™, an advanced clinical-stage immunotherapy targeting inflammatory conditions associated with aging, with a primary focus on age-related osteoarthritis. In addition to its clinical programs, Enlivex operates a prediction markets treasury strategy built around the Rain protocol, the leading decentralized prediction markets infrastructure on Arbitrum. This dual strategy combines the development of quality longevity therapeutics with exposure to the emerging prediction markets ecosystem.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements may be identified by words such as "expects," "plans," "projects," "will," "may," "anticipates," "believes," "should," "would," "could," "intends," "estimates," "suggests," "target," "has the potential to," "goal," and other words of similar meaning, including statements relating to the anticipated benefits of the Company's digital asset treasury strategy; the assets to be held by the Company; the expected future market, price, trading activity, and liquidity of the RAIN token; the impact of expanded exchange listings and increased token liquidity on market participation and accessibility; the potential effects of digital asset liquidity on the liquidity of the Company's ordinary shares; macroeconomic, political, and regulatory conditions surrounding digital assets; the Company's plans for value creation and strategic positioning; market size and growth opportunities; regulatory conditions; competitive position; technological and market trends; future financial condition and performance; expected clinical trial results; market opportunities for the results of current clinical studies and preclinical experiments; and the effectiveness of, and market opportunities for, Allocetra™ programs.
Each forward-looking statement contained in this press release is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statement. Applicable risks and uncertainties include, among others, the risk of failure to realize the anticipated benefits of the Company's digital asset treasury strategy; changes in business, market, financial, political, and regulatory conditions; risks relating to the Company's operations and business, including the highly volatile nature of the price, trading volume, and liquidity of RAIN and other cryptocurrencies; risks associated with digital asset exchange listings, trading venues, and market infrastructure; the risk that the price and liquidity of the Company's ordinary shares may be correlated with the price or liquidity of the digital assets it holds; risks related to increased competition in the industries in which the Company operates; risks relating to significant legal, commercial, regulatory, and technical uncertainty regarding digital assets generally; risks relating to the treatment of crypto assets for U.S. and foreign tax purposes; and those risks and uncertainties identified in the Company's filings with the Securities and Exchange Commission. The forward-looking statements in this press release speak only as of the date of this document, and the Company undertakes no obligation to update or revise any of these statements, except as required by applicable law.
ENLIVEX CONTACT Shachar Shlosberger, CFO Enlivex Ltd. shachar@enlivex.com
1 Source: https://dune.com/rain_predictions/rain; https://defillama.com/protocols/prediction-market;
